<DOC>
	<DOCNO>NCT00229502</DOCNO>
	<brief_summary>The purpose study examine compare change specific think skill patient RRMS receive treatment one three immunomodulatory medication ( Avonex , Copaxone , Rebif ) .</brief_summary>
	<brief_title>Cognitive Effects Immunomodulatory Drugs MS</brief_title>
	<detailed_description>In addition study compare patient ' personal view , change physical disability , frequency severity relapse three year period .</detailed_description>
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis , Relapsing-Remitting</mesh_term>
	<criteria>Diagnosis RRMS least one year , Currently one three immunomodulatory drug ( Avonex , Copaxone , Rebif ) , Visual Acuity 20/50 good , patient four color vision , Must least high school education History head injury , drug/alcohol abuse , and/or psychiatric problem , current diagnosis severe lifethreatening disease MS , currently take immunosuppressant medication , reside great 200 mile study site</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>March 2012</verification_date>
</DOC>